Pro-actively addressing the challenges for an effective uptake of COVID-19 vaccination in Belgium: a transdisciplinary approach

Grant number: G0H5520N

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $288,624.96
  • Funder

    FWO Belgium
  • Principal Investigator

    Unspecified Koen Peeters, Charlotte Gryseels, Anne-mieke Vandamme, Nico Vandaele, Corinne Vandermeulen
  • Research Location

    Belgium
  • Lead Research Institution

    Instituut voor Tropische Geneeskunde, KU Leuven
  • Research Priority Alignment

    N/A
  • Research Category

    Policies for public health, disease control & community resilience

  • Research Subcategory

    Approaches to public health interventions

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Tackling the current COVID-19 pandemic will require effective vaccines for individual protection and potential group immunity to reduce transmission. If vaccines are developed, Belgium will likely face challenges with COVID-19 vaccine uptake. Heightened antivaccination sentiments are proliferating around the world. These sentiments are related to 'post-truth' perceptions, i.e. increased skepticism towards science and authorities in general, as well as skepticism specifically towards vaccine safety and effectiveness. Emerging signs of escalating mistrust can be linked to such sentiments and perceptions, compounded with pandemic anxieties and incertitude ('insufficient knowledge') around scientific expertise and the politics of pandemic management. A strategy is urgently needed to guide Belgian public health authorities on how to promote vaccine acceptance among the population. This project aims to use an innovative hybrid monitoring tool to assess both on-line and onthe- ground vaccine sentiments qualitatively and quantitatively. Interventions that are responsive to the identified emerging vaccine concerns and controversies will be co-created with community and public health stakeholders and aim to place public health agencies in a position to pro-actively counteract vaccine hesitancy prior to COVID-19 vaccination campaigns in Belgium.